These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26101276)

  • 1. Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
    Ibitokou SA; Denoeud-Ndam L; Ezinmegnon S; Ladékpo R; Zannou DM; Massougbodji A; Girard PM; Cot M; Luty AJ; Ndam NT
    Am J Trop Med Hyg; 2015 Aug; 93(2):287-92. PubMed ID: 26101276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
    Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
    Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.
    Green M; Otieno K; Katana A; Slutsker L; Kariuki S; Ouma P; González R; Menendez C; ter Kuile F; Desai M
    Malar J; 2016 Jan; 15():7. PubMed ID: 26732683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.
    Klement E; Pitché P; Kendjo E; Singo A; D'Almeida S; Akouete F; Akpaloo Y; Tossa K; Prince-Agbodjan S; Patassi A; Caumes E
    Clin Infect Dis; 2014 Mar; 58(5):651-9. PubMed ID: 24336820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Cytokines Associated with Poor Pregnancy Outcomes in Beninese Exposed to Infection with Plasmodium falciparum.
    Hountohotegbe T; Gbedande K; Agbota G; Ibitokou S; Massougbodji A; Deloron P; Fievet N; Luty AJF
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32513854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
    Malamba SS; Mermin J; Reingold A; Lule JR; Downing R; Ransom R; Kigozi A; Hunt BM; Hubbard A; Rosenthal PJ; Dorsey G
    Am J Trop Med Hyg; 2006 Sep; 75(3):375-80. PubMed ID: 16968909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
    Serra-Casas E; Menéndez C; Bardají A; Quintó L; Dobaño C; Sigauque B; Jiménez A; Mandomando I; Chauhan VS; Chitnis CE; Alonso PL; Mayor A
    J Infect Dis; 2010 Jan; 201(1):123-31. PubMed ID: 19954383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
    Huijben S; Macete E; Mombo-Ngoma G; Ramharter M; Kariuki S; Desai M; Shi YP; Mwangoka G; Massougbodji A; Cot M; Ndam NT; Uberegui E; Gupta H; Cisteró P; Aponte JJ; González R; Menéndez C; Mayor A
    J Infect Dis; 2020 Jan; 221(2):293-303. PubMed ID: 31677349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.
    Quelhas D; Puyol L; Quintó L; Nhampossa T; Serra-Casas E; Macete E; Aide P; Sanz S; Aponte JJ; Doolan DL; Alonso PL; Menéndez C; Dobaño C
    BMC Immunol; 2012 Jan; 13():5. PubMed ID: 22280502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.
    Newman PM; Wanzira H; Tumwine G; Arinaitwe E; Waldman S; Achan J; Havlir D; Rosenthal PJ; Dorsey G; Clark TD; Cohan D
    Malar J; 2009 Nov; 8():254. PubMed ID: 19912657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
    Naniche D; Lahuerta M; Bardaji A; Sigauque B; Romagosa C; Berenguera A; Mandomando I; David C; Sanz S; Aponte J; Ordi J; Alonso P; Menendez C
    HIV Med; 2008 Oct; 9(9):757-64. PubMed ID: 18651857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 producing monocytes and IFN-gamma and TNF-alpha producing T-lymphocytes are increased in placentas infected by Plasmodium falciparum.
    Diouf I; Fievet N; Doucouré S; Ngom M; Andrieu M; Mathieu JF; Gaye A; Thiaw OT; Deloron P
    J Reprod Immunol; 2007 Jun; 74(1-2):152-62. PubMed ID: 17194481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial.
    Manirakiza A; Tondeur L; Ketta MYB; Sepou A; Serdouma E; Gondje S; Bata GGB; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Briand V; Lombart JP; Vray M
    Trop Med Int Health; 2021 Oct; 26(10):1314-1323. PubMed ID: 34407273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
    Mbonye AK; Birungi J; Yanow SK; Shokoples S; Malamba S; Alifrangis M; Magnussen P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5475-82. PubMed ID: 26124154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
    Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Pregnancy-associated Malaria on T Cell Cytokines in Cameroonian Women.
    Megnekou R; Lissom A; Bigoga JD; Djontu JC
    Scand J Immunol; 2015 Jun; 81(6):508-14. PubMed ID: 25736985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
    Shah SN; Smith EE; Obonyo CO; Kain KC; Bloland PB; Slutsker L; Hamel MJ
    J Infect Dis; 2006 Dec; 194(11):1519-28. PubMed ID: 17083036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.